Nothing Special   »   [go: up one dir, main page]

Kim et al., 2014 - Google Patents

Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models

Kim et al., 2014

View HTML
Document ID
7416301016792384329
Author
Kim H
Raphael A
LaDow E
McGurk L
Weber R
Trojanowski J
Lee V
Finkbeiner S
Gitler A
Bonini N
Publication year
Publication venue
Nature genetics

External Links

Snippet

Amyotrophic lateral sclerosis (ALS) is a fatal, late-onset neurodegenerative disease primarily affecting motor neurons. A unifying feature of many proteins associated with ALS, including TDP-43 and ataxin-2, is that they localize to stress granules. Unexpectedly, we …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/558—Immunoassay; Biospecific binding assay using diffusion or migration of antigen or antibody
    • G01N33/561—Immunoelectrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders

Similar Documents

Publication Publication Date Title
Kim et al. Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models
Wilson et al. ER-mitochondria contact sites in neurodegeneration: genetic screening approaches to investigate novel disease mechanisms
Pokatayev et al. Homeostatic regulation of STING protein at the resting state by stabilizer TOLLIP
Schrank et al. Nuclear ARP2/3 drives DNA break clustering for homology-directed repair
Bae et al. LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation
Stoica et al. ER–mitochondria associations are regulated by the VAPB–PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43
Liu et al. Endocytosis regulates TDP-43 toxicity and turnover
Petkovic et al. The SNARE Sec22b has a non-fusogenic function in plasma membrane expansion
Boeynaems et al. Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD
Atwal et al. Kinase inhibitors modulate huntingtin cell localization and toxicity
Bellani et al. GRP78 clustering at the cell surface of neurons transduces the action of exogenous alpha-synuclein
Armakola et al. Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models
Doñate-Macian et al. The TRPV4 channel links calcium influx to DDX3X activity and viral infectivity
Mecozzi et al. Pharmacological chaperones stabilize retromer to limit APP processing
Ismail et al. The RNF138 E3 ligase displaces Ku to promote DNA end resection and regulate DNA repair pathway choice
Cao et al. Actin and Arf1-dependent recruitment of a cortactin–dynamin complex to the Golgi regulates post-Golgi transport
Tsai et al. Functional interaction between FOXO3a and ATM regulates DNA damage response
Chih et al. A ciliopathy complex at the transition zone protects the cilia as a privileged membrane domain
Wei et al. Amyloid beta from axons and dendrites reduces local spine number and plasticity
Ma et al. Requirement for Nudel and dynein for assembly of the lamin B spindle matrix
Kim et al. Functional genomic screen for modulators of ciliogenesis and cilium length
Elden et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS
Pandey et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS
Freir et al. Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites
Watanabe et al. Aggresome formation and liquid–liquid phase separation independently induce cytoplasmic aggregation of TAR DNA-binding protein 43